A first generation CAR containing the CE7 scFv, a CD4 transmembrane domain, and the CD3ζ intracellular signaling domain (CE7R CAR) demonstrated preclinical activity in xenograft models of neuroblastoma (65). The gene discussed is CD247; the disease is neuroblastoma.